451 related articles for article (PubMed ID: 23829186)
21. Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering.
Chen JY; Wu H; Guo CY; Zhu B; Ren GB
Int J Pharm; 2019 Dec; 572():118776. PubMed ID: 31678374
[TBL] [Abstract][Full Text] [Related]
22. Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations.
Hamza Yel-S; Aburahma MH
Drug Dev Ind Pharm; 2010 Mar; 36(3):337-49. PubMed ID: 19722915
[TBL] [Abstract][Full Text] [Related]
23. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
25. Supramolecular Cocrystals of Gliclazide: Synthesis, Characterization and Evaluation.
Chadha R; Rani D; Goyal P
Pharm Res; 2017 Mar; 34(3):552-563. PubMed ID: 28035627
[TBL] [Abstract][Full Text] [Related]
26. Role of Structure, Microenvironmental pH, and Speciation To Understand the Formation and Properties of Febuxostat Eutectics.
Jagia M; Daptardar R; Patel K; Bansal AK; Patel S
Mol Pharm; 2019 Nov; 16(11):4610-4620. PubMed ID: 31573811
[TBL] [Abstract][Full Text] [Related]
27. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture.
Padrela L; de Azevedo EG; Velaga SP
Drug Dev Ind Pharm; 2012 Aug; 38(8):923-9. PubMed ID: 22092083
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
29. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
30. Modulating Pharmaceutical Properties of Berberine Chloride through Cocrystallization with Benzendiol Isomers.
Guo H; Liu S; Sun CC
Pharm Res; 2023 Dec; 40(12):2791-2800. PubMed ID: 37226026
[TBL] [Abstract][Full Text] [Related]
31. Crystal engineering to improve physicochemical properties of mefloquine hydrochloride.
Yadav AV; Dabke AP; Shete AS
Drug Dev Ind Pharm; 2010 Sep; 36(9):1036-45. PubMed ID: 20334542
[TBL] [Abstract][Full Text] [Related]
32. Structural Characterization and Pharmaceutical Properties of Three Novel Cocrystals of Ethenzamide With Aliphatic Dicarboxylic Acids.
Kozak A; Marek PH; Pindelska E
J Pharm Sci; 2019 Apr; 108(4):1476-1485. PubMed ID: 30414866
[TBL] [Abstract][Full Text] [Related]
33. Novel Salt-Cocrystals of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd-Even Alternation in Physicochemical Properties.
Wang L; Liu S; Chen JM; Wang YX; Sun CC
Mol Pharm; 2021 Apr; 18(4):1758-1767. PubMed ID: 33656348
[TBL] [Abstract][Full Text] [Related]
34. X-Ray Diffraction and Theoretical Calculation-Supported Formation of Polymorphic Cocrystals Discovered Through Thermal Methods: A Case Study.
Zhou Z; Calatayud M; Contreras-García J; Li L; Tong HHY; Zheng Y
J Pharm Sci; 2019 Oct; 108(10):3340-3347. PubMed ID: 31145922
[TBL] [Abstract][Full Text] [Related]
35. Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies.
Jindal A; Singh R; Tomar S; Dureja J; Karan M; Chadha R
Pharm Res; 2021 Dec; 38(12):2129-2145. PubMed ID: 34904202
[TBL] [Abstract][Full Text] [Related]
36. Preparation and physicochemical characterization of acyclovir cocrystals with improved dissolution properties.
Bruni G; Maietta M; Maggi L; Mustarelli P; Ferrara C; Berbenni V; Milanese C; Girella A; Marini A
J Pharm Sci; 2013 Nov; 102(11):4079-86. PubMed ID: 24030886
[TBL] [Abstract][Full Text] [Related]
37. Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies.
Drozd KV; Manin AN; Churakov AV; Perlovich GL
Eur J Pharm Sci; 2017 Mar; 99():228-239. PubMed ID: 28011126
[TBL] [Abstract][Full Text] [Related]
38. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
Rahman Z; Samy R; Sayeed VA; Khan MA
Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
[TBL] [Abstract][Full Text] [Related]
40. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method.
Chaudhari KR; Savjani JK; Savjani KT; Shah H
Drug Dev Ind Pharm; 2021 Oct; 47(10):1633-1642. PubMed ID: 35156497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
